Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver disease.

Akshat GoelBethany TuckerLorena Soler CasaleTassos Grammatikopoulos

Published in: JPGN reports (2024)

We suggest that Odevixibat may be used as an adjunctive drug in refractory pruritus and could be started early in the course of disease if clinically and phenotypically indicated.

Keyphrases

atopic dermatitis
copy number
genome wide
smoking cessation